Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kjersti Sellæg"'
Autor:
Kjersti Sellæg, Ruth Schwienbacher, Mathias Kranz, Anna Engan Aamodt, Anna M. Wirsing, Gerd Berge, Elin Hadler-Olsen, Synnøve Norvoll Magnussen
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Oral tongue squamous cell carcinoma (OTSCC) is the most common cancer of the oral cavity and is associated with high morbidity due to local invasion and lymph node metastasis. Tumor infiltrating lymphocytes (TILs) are associated with good prognosis i
Externí odkaz:
https://doaj.org/article/5f4d3a3ca9ea48a8868633d6ca5c36af
Autor:
Synne Jenum, Kristian Tonby, Corina S. Rueegg, Morten Rühwald, Max P. Kristiansen, Peter Bang, Inge Christoffer Olsen, Kjersti Sellæg, Kjerstin Røstad, Tehmina Mustafa, Kjetil Taskén, Dag Kvale, Rasmus Mortensen, Anne Ma Dyrhol-Riise
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Modulating the host immune response during tuberculosis is an emerging and critical advance in the therapeutic approach. Here the authors present data from a first-in-human phase I/II randomised trial on the safety and immunogenicity of adjuvant ther
Externí odkaz:
https://doaj.org/article/6152a3f5e03b4794a0706ed5b7ac2925
Autor:
Morten Ruhwald, Max Kristiansen, Inge C. Olsen, Synne Jenum, Rasmus Mortensen, Dag Kvale, Corina S. Rueegg, Anne Ma Dyrhol-Riise, Kristian Tonby, Kjetil Taskén, Kjerstin Røstad, Peter Bang, Kjersti Sellæg, Tehmina Mustafa
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Host-directed-therapy strategies are warranted to fight tuberculosis. Here we assess the safety and immunogenicity of adjunctive vaccination with the H56:IC31 candidate and cyclooxygenase-2-inhibitor treatment (etoricoxib) in pulmonary and extra-pulm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b6149b86daa0fca80c1dba63eedcc6
https://hdl.handle.net/11250/2976013
https://hdl.handle.net/11250/2976013
Publikováno v:
OncoTarget
Oncotarget
Oncotarget
// Robin Mjelle 1 , Kjersti Sellaeg 1 , Pal Saetrom 1, 2 , Liv Thommesen 3 , Wenche Sjursen 1, 4 and Eva Hofsli 1, 5 1 Department of Clinical and Molecular Medicine, NO-7491 Trondheim, Norway 2 Department of Computer Science, Norwegian University of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8579d9076b7c4415a00b0ba88cd5bc26
https://hdl.handle.net/11250/2779865
https://hdl.handle.net/11250/2779865